期刊文献+

干扰素调节因子-5 rs2004640的T等位基因与类风湿关节炎的临床表现的相关性

Association of interferon regulatory factor 5 gene rs2004640 T alleles with clinical manifestation of rheumatoid arthritis
下载PDF
导出
摘要 目的探讨干扰素调节因子-5(IRF-5)rs2004640位点T等位基因与类风湿关节炎(RA)的临床表现的相关性。方法采用聚合酶链反应-连接酶检测反应(PCR-LDR)对136例RA患者进行IRF-5rs2004640位点的单核苷酸多态性(SNP)分型。记录患者的临床表现、X线分期,检测红细胞沉降率、类风湿因子水平。结果 X线分期为Ⅲ+Ⅳ期组RA患者的T等位基因阳性率显著高于Ⅰ+Ⅱ期组(P=0.018)。关节外表现<3个的RA患者的T等位基因阳性率显著多于关节外表现≥3个的RA患者(P<0.01)。结论 IRF-5 rs2004640 T等位基因与RA患者关节破坏程度(X线分期)和关节外表现有关。 Objective To study the correlation of interferon regulatory factor 5(IRF-5) gene rs2004640 T Alleles with the clinical manifestation of rheumatoid arthritis (RA). Methods The single-nucleotide polymorphism of IRF-5 rs2004640 was genotyped by polymerase chain reaction-tigase detection reaction(POR-LDR) in 139 RA patients. The clinical manifestations, X-ray stages, ESR, and levels of rheumatoid factor were all observed. Results The T allele frequency of IRF-5 rs2004640 was significantly higher in RA patients in Ⅲ+Ⅳ stage of X- ray than in those in Ⅰ + Ⅱ stage of X-ray(P=0. 039). The T allele frequency of IRF-5 rs2004640 in RA patients who had less than three extraarticular manifestations was significantly higher than that in patients who had 3 or more extraarticuiar manifestations (P〈0.01). Conclusion IRF-5 gene rs2004640 T Alleles is associated with bone damage degree (X-ray stage) and extraarticular manifestations in RA.
出处 《上海医学》 CAS CSCD 北大核心 2011年第7期540-542,共3页 Shanghai Medical Journal
基金 河北省科技厅科技公关计划(10276105D-70)
关键词 干扰素调节因子-5 T等位基因 类风湿关节炎 关节外表现 X线分期 Interferon regulatory factor 5 T Alleles Rheumatoid arthritis Extraarticular manifestations Stage of X-ray
  • 相关文献

参考文献10

  • 1SIGURDSSON S, PADYUKOV L, KURREEMAN F A, et al. Association of a haplotype in the promoter region ofthe interferon regulatory factor 5 gene with rheumatoid arthritis [J]. Arthritis Rheum, 2007, 56(7): 2202-2210.
  • 2SCHOENEMEYER A, BARNES B J, MANCL M E, et al. The interferon regulatory factor, IRFS, is a central mediator of toll-like receptor 7 signaling [J].J Biol Chem, 2005, 280(17): 17005-1712.
  • 3沈桂英,舒荣,崔刘福,杨文浩,宋海澄,韩依轩,陆艳萍,于萍,王建,王洁蕊.干扰素调节因子-5基因多态性与类风湿关节炎的相关性[J].苏州大学学报(医学版),2010,30(6):1246-1248. 被引量:1
  • 4WEYANDC M, HICOK K C, CONN D L, et al. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis[J]. Ann Intern Med, 1992, 117 (10) 801-806.
  • 5WEYAND C M, XIE C, GORONZY J J. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis[J]. J Clin Invest, 1992, 89(6) : 2033- 2039.
  • 6IRIGOYEN P, LEE A T, WENER M H, et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles[J]. Arthritis Rheum, 2005, 52 (12): 3813- 3818.
  • 7PLENGE R M, PADYUKOV L, REMMERS E F, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4[J]. Am J Hum Genet, 2005, 77(6) 1044-1060.
  • 8VAN DER HELM-VAN MIL A H, VERPOORT K N, BREEDVELD F C, et al. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis [J]. Arthritis Res Ther, 2005, 7(5): R949-R958.
  • 9KROOT E J, DE JONG B A, VAN LEEUWEN M A, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis [J]. Arthritis Rheum, 2000, 43(8) : 1831-1835.
  • 10BONGI S M, MANETTI R, MELCHIORRE D, et al. Anticyclic citrullinated peptide antibodies are highly associated with severe bone lesions in rheumatoid arthritis anti-CCP and bone damage in RA[J].Autoimmunity, 2004, 37(6-7): 495-501.

二级参考文献10

  • 1[asstedt SJ, Clegg DO, et al. HLA-linked rheumatoid arlristis[J]. Am J Hum Genet, 1994, 55(4) :738 -746.
  • 2Begovich AB, Carlton VE, Honigberg LA, et al. A missense single-nucleotidepolymorphism in a gene encoding a protein tyrosine phosphatase ( PTPN22 ) is associated with rheumatoid arthritis[J]. Am J Hum Genet,2004,75(2) :330 -337.
  • 3Kang CP,Lee HS,Ju H, et al. A functional haplotypeof the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans [ J ]. Arthritis Rheum, 2006,54 (1) :90 -96.
  • 4Garnier S, Dieude P, Michou L,et al. IRF5 rs2004640-T al- lele,the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis [ J]. Ann Rheum Dis 2007,66(6) :828 - 831.
  • 5Schoenemeyer A, Barnes BJ, Mancl ME, et al. The interferon regulatory factor, IRFS, is a centralmediator of Toil-like receptor 7 signaling. J Biol Chem, 2005,280 ( 6 ) : 17005 - 17012.
  • 6Barnes B J, Richards J, Mancl M, et al. Global and distinct targets of IRF-5 and IRF-7 during innateresponse to viral infection[J]. J Biol Chem,2004,279(43) :45194 -45207.
  • 7Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, et al. The expression of Toll-likereceptors 3 and 7 in rheumatoid arthritis synovium is increased costimulation of Toll-like receptors 3,4, and 7/8 results in synergistic cytokine production by dendritic cells [ J ]. Arthritis Rheum, 2005,52 (18) :2313 -2322.
  • 8Sigurdsson S, Padyukov L, Kurreeman FA, et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis[J]. Arthritis Rheum,2007,56(7 ) :2202 - 2210.
  • 9van der Helm-van Mil AH, Verpoort KN, Breedveld FC, et al. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis [ J ]. Arthritis ResTher,2005,7 ( 5 ) :949 - 958.
  • 10Verpoort KN,van Gaalen FA,van der Helmvan Mil AH, et al. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibodynegative rheumatoid arthritis[ J]. Arthritis Rheum,2005 ;52(10) :3058 -3062.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部